Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.30 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1004375 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TSHRKDM4EHPGDHSD17B10 | |
| SCHEMBL2863000 | 0.80 | ALDH1A1 (0.41) | ALDH1A1TSHRKDM4EHPGDHSD17B10 | |
| Acrylamide SCHEMBL10534971 | 0.79 | ALDH1A1 (0.45) | ALDH1A1TSHRKDM4EHPGDHSD17B10 | |
| SCHEMBL15704573 | 0.79 | ALDH1A1 (0.44) | ALDH1A1TSHRKDM4EHPGDMAPT | |
| SCHEMBL24197143 | 0.78 | ALDH1A1 (0.40) | ALDH1A1TSHRKDM4EHPGDHSD17B10 | |
| SCHEMBL30053495 | 0.78 | ALDH1A1 (0.48) | ALDH1A1TSHRKDM4EHPGDHSD17B10 | |
| SCHEMBL12095445 | 0.77 | ALDH1A1 (0.43) | ALDH1A1TSHRCYP3A4 | |
| SCHEMBL10317011 | 0.77 | ALDH1A1 (0.48) | ALDH1A1TSHRHPGDCYP3A4 | |
| SCHEMBL489258 | 0.77 | ALDH1A1 (0.43) | ALDH1A1TSHRHPGDMAPTLMNA | |
| SCHEMBL12018275 | 0.77 | ALDH1A1 (0.42) | ALDH1A1TSHRKDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3881942-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | Molecular Plasma Group SA (LU) | 2021-09-22 | — | — | EP | disclosed |
| EP-3560501-A1 | DOSAGE REGIMEN FOR SAPACITABINE AND DECITABINE IN COMBINATION FOR TREATING ACUTE MYELOID LEUKEMIA | Cyclacel Limited (GB) | 2019-10-30 | — | — | EP | disclosed |
| US-10205103-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10205103-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNE2, CRY2 | ALDH1A1 527/4885TSHR 4332/4885KDM4E 3764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.